Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Hemophilia
Do you incorporate DVT prophylaxis after joint arthroscopy in a patient with hemophilia?
If so, what is your preferred agent?
Related Questions
Are there any circumstances where you would consider bridging for patients on DOACs?
Are SCDs contraindicated in patients with acute DVTs?
What additional testing is recommended with heterozygous HFE C282Y mutation whose ferritin is elevated and transferrin saturation percentage is at baseline?
For a patient with May-Thurner syndrome and DVT, would you recommend anticoagulation for 3-6 months or indefinitely?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
How do you manage mild Type 1 von Willebrand disease undergoing wisdom teeth removal?
Is there a correlation between spleen size and degree of thrombocytopenia?
Would you anticoagulate a patient with splenic infarctions in the setting of CMV viremia?
How is transferrin saturation a reliable indicator for any parameter if serum iron is not reliable?
